Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025Asian Journal of Organic Chemistry

Design and Development of New Benzopyrazole Derivatives as Selective Inhibitors of Helicobacter pylori IMPDH

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSachin PuriSSShalini ShaliniKJKapil Juvale

Discussion

Loading...

Member takes

Overview

This study demonstrates that new benzopyrazole inhibitors significantly reduce H. pylori growth, indicating their potential as alternatives to antibiotics.

Key Points

  • New benzopyrazole derivatives significantly inhibit Helicobacter pylori growth, presenting a novel treatment pathway.
  • The identified compounds, SN-8.1 and SN-8.2, have IC50 values of 0.122 and 0.187 µM against Hp IMPDH.
  • Observational analysis reveals minimal impact on human IMPDH2, emphasizing the selectivity of these inhibitors.
  • These results highlight the compounds' non-toxicity and present a promising strategy for combating antibiotic-resistant H. pylori.

Cite This Study

Puri et al. (2025) studied this question.

synapsesocial.com/papers/68af7b2a7567bf4f94ff3437https://doi.org/10.1002/ajoc.202500584
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In silico Analysis to Search for an Alternative Inhibitor of Biofilm Production by Helicobacter pylori2025
  2. 2Monoterpene Indole Alkaloids with Antimicrobial Activity Against Helicobacter pylori2025
  3. 3Dual-targeting 5-nitroimidazole ethers eradicate H. pylori by induction of stress and disabling its adaptive response2025
  4. 4Research progress of potassium-competitive acid blockers in the treatment of <i>Helicobacter pylori</i>2025 · 12 citations
  5. 5Assessment of Some Aminoglycoside Drugs Repurposing as Helicobacter pylori Urease Enzyme Inhibitors by In silico and In vitro2025